United Pharm (033270)

Currency in KRW
18,810
+420(+2.28%)
Closed·
033270 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
18,43018,820
52 wk Range
17,63022,450
Key Statistics
Bid/Ask
18,800.00 / 18,810.00
Prev. Close
18,810
Open
18,500
Day's Range
18,430-18,820
52 wk Range
17,630-22,450
Volume
29.39K
Average Volume (3m)
36.33K
1-Year Change
4.6745%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
033270 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
30,000
Upside
+59.49%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

United Pharm Company Profile

Korea United Pharm Inc. engages in the manufacture and sale of pharmaceutical products in South Korea. It offers products in the areas of respiratory system, musculo-skeletal system, gastro-intestinal tract system, cardiovascular system, anti-cancer, anti-infectives, allergy, immune system, central nervous system, and other diseases, as well OTC drugs. The company also exports its products to approximately 40 countries. Korea United Pharm Inc. was founded in 1987 and is headquartered in Seoul, South Korea.

Employees
665

Compare 033270 to Peers and Sector

Metrics to compare
033270
Peers
Sector
Relationship
P/E Ratio
0.0x10.2x−0.6x
PEG Ratio
0.000.010.00
Price/Book
0.0x1.2x2.6x
Price / LTM Sales
0.0x0.7x3.4x
Upside (Analyst Target)
0.0%35.6%41.5%
Fair Value Upside
Unlock8.6%4.4%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 30,000
(+59.49% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1,260.76%
Dividend Yield
2.39%
Industry Median 0.85%
Annualised payout
450.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Nov 13, 2025
EPS / Forecast
-- / --
Revenue / Forecast
74.40B / 75.79B
EPS Revisions
Last 90 days

033270 Income Statement

People Also Watch

1,580,000
010130
+1.61%
510,000
005380
-3.59%
56,300
005850
-8.90%
113,000
011790
-2.67%
269,000
014680
-2.54%

FAQ

What Stock Exchange Does United Pharm Trade On?

United Pharm is listed and trades on the Seoul Stock Exchange stock exchange.

What Is the Stock Symbol for United Pharm?

The stock symbol for United Pharm is "033270."

What Is the United Pharm Market Cap?

As of today, United Pharm market cap is 276.75B.

What Is United Pharm's Earnings Per Share (TTM)?

The United Pharm EPS (TTM) is 1,260.76.

When Is the Next United Pharm Earnings Date?

United Pharm will release its next earnings report on 17 Mar 2026.

From a Technical Analysis Perspective, Is 033270 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has United Pharm Stock Split?

United Pharm has split 2 times.

How Many Employees Does United Pharm Have?

United Pharm has 665 employees.

What is the current trading status of United Pharm (033270)?

As of 25 Jan 2026, United Pharm (033270) is trading at a price of 18,810, with a previous close of 18,810. The stock has fluctuated within a day range of 18,430 to 18,820, while its 52-week range spans from 17,630 to 22,450.

What Is United Pharm (033270) Price Target According to Analysts?

The average 12-month price target for United Pharm is KRW30,000, with a high estimate of KRW30000 and a low estimate of KRW30000. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +59.49% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.